The nonclassical binding kinetics of IGF-I and insulin to their respective receptors, suggestive of negative cooperativity, can be readily explained by our recently proposed novel binding mechanism whereby the bivalent ligand bridges the two receptor alpha-subunits alternatively at opposite sites in a symmetrical receptor structure. The bivalent binding mechanism also explains bell-shaped bioactivity curves. The possible role of different binding modes versus differences in downstream signaling by insulin and IGF-I in producing specific mitogenic or metabolic responses is discussed.
Larger types of small unmanned aerial vehicles (UAVs) are beginning to be used in the United States and Europe for commercial transportation. Additionally, some blood product transport systems have been commercialized in Rwanda and other countries and used in pandemic operations for the coronavirus disease 2019 (COVID-19) in infected areas. Conversely, implementing goods transportation for commercial purposes in Japan has been difficult, especially in urban areas, due to national legislation. This study examined UAV-assisted transportation in Japan, a natural disaster hotspot, with a focus on the potential uses of UAVs in situations where traffic blockages make ground transportation impossible. UAVs were used to transport 17 kg of medical supplies belonging to a disaster medical assistance team (DMAT), along with 100 emergency meals. We also transported insulin under controlled-temperature conditions, as well as many other emergency supplies. Using UAVs to transport emergency supplies could be an effective approach when dealing with disasters. This paper summarizes the effectiveness of this approach for medical care and disaster response activities. We present a method for using drones to bridge the gap between medical and firefighting personnel, such as DMAT personnel, who are engaged in life-saving activities at the time of a disaster, and those who are unable to transport necessary goods by land using terrestrial vehicles due to traffic interruptions.
Summary: Glucagon stimulates hepatic glucose production by activating specific glucagon receptors in the liver, which in turn increase hepatic glycogenolysis as well as gluconeogenesis and ureagenesis from amino acids. Conversely, glucagon secretion is regulated by concentrations of glucose and amino acids. Disruption of glucagon signaling in rodents results in grossly elevated circulating glucagon levels but no hypoglycemia. Here, we describe a patient carrying a homozygous G to A substitution in the invariant AG dinucleotide found in a 3′ mRNA splice junction of the glucagon receptor gene. Loss of the splice site acceptor consensus sequence results in the deletion of 70 nucleotides encoded by exon 9, which introduces a frame shift and an early termination signal in the receptor mRNA sequence. The mutated receptor neither bound125I-labeled glucagon nor induced cAMP production upon stimulation with up to 1 µM glucagon. Despite the mutation, the only obvious pathophysiological trait was hyperglucagonemia, hyperaminoacidemia and massive hyperplasia of the pancreatic α-cells assessed by histology. Our case supports the notion of a hepato–pancreatic feedback system, which upon disruption leads to hyperglucagonemia and α-cell hyperplasia, as well as elevated plasma amino acid levels. Together with the glucagon-induced hypoaminoacidemia in glucagonoma patients, our case supports recent suggestions that amino acids may provide the feedback link between the liver and the pancreatic α-cells.Learning points: Loss of function of the glucagon receptor may not necessarily lead to the dysregulation of glucose homeostasis. Loss of function of the glucagon receptor causes hyperaminoacidemia, hyperglucagonemia and α-cell hyperplasia and sometimes other pancreatic abnormalities. A hepato–pancreatic feedback regulation of the α-cells, possibly involving amino acids, may exist in humans.
Unmanned aerial vehicles (UAVs), or drones, are used in Rwanda for transfusion transport, but they have not yet been used in Japan. This technology holds promise for transporting medical supplies during disasters or to remote places where the terrain makes it difficult to travel by land. One of the difficulties in using UAVs is the temperature-control requirements for red blood cell (RBC) solutions, i.e., 2 °C to 6 °C according to Japanese regulations. This study aimed to describe the effectiveness of UAV-based transport of RBC solution. For testing, we gradually increased the UAV travel distance, monitored the temperature of the RBC solution, and conducted laboratory tests to check the integrity of the blood sample. Lactate dehydrogenase (LD) was used as a hemolytic index to indicate the effect of the UAV flight on the blood samples. The UAV was able to exceed 7 km of travel distance despite the relatively heavy load needed for the RBC solution storage. The LD level was not significantly different between the flight and non-flight (control) samples. However, we were not able to completely maintain a temperature of 2 °C to 6 °C; nonetheless, the deviation was within the safe range.
A 46-year-old woman with rheumatoid arthritis had been on non-steroidal antiinflammatory agents for eighteen years until she developed cushingoid features and hypertension resistant to antihypertensive drugs. She had high plasma cortisol and 24 h urinary 17-hydroxycorticosteroids (17HCS) which were not suppressed by 8 mg dexamethasone per day for two days. The circadian rhythm of plasma cortisol was absent and plasma ACTH concentrations were suppressed before and after intravenous administration of CRH. Abdominal computed tomography demonstrated a tumor (3.0 x 3.0 x 2.3 cm) in the right adrenal gland and a 131I-6 beta-19-nor-methylcholesterol scan revealed marked uptake on the same side. The patient underwent a right adrenalectomy and the diagnosis of a cortisol secreting benign adenoma was histologically confirmed. Blood pressure declined and cushingoid features regressed, but three months after the operation and while the patient was on replacement, she complained of pain on motion, marked tenderness and swelling of fingers, wrists, elbows, knees and foot joints, and had very high rheumatoid factors. Treatment with immunosuppressive drugs and oral and intraarticular administration of glucocorticoids were necessary to relieve the clinical symptoms of rheumatoid arthritis. In summary, we report a patient with rheumatoid arthritis and Cushing's syndrome due to an adrenal adenoma, in whom rheumatoid arthritis was exacerbated after curing the Cushing's syndrome. This suggests that it is imperative to follow the development and/or course of autoimmune diseases after the treatment of Cushing's syndrome.